rs2171492
From SNPedia
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(T;T) | 2 | Higher prostate cancer risk |
Make rs2171492(G;G) |
Make rs2171492(G;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 7 |
Position | 130310900 |
Gene | CPA4 |
is a | snp |
is | mentioned by |
dbSNP | rs2171492 |
dbSNP (classic) | rs2171492 |
ClinGen | rs2171492 |
ebi | rs2171492 |
HLI | rs2171492 |
Exac | rs2171492 |
Gnomad | rs2171492 |
Varsome | rs2171492 |
LitVar | rs2171492 |
Map | rs2171492 |
PheGenI | rs2171492 |
Biobank | rs2171492 |
1000 genomes | rs2171492 |
hgdp | rs2171492 |
ensembl | rs2171492 |
geneview | rs2171492 |
scholar | rs2171492 |
rs2171492 | |
pharmgkb | rs2171492 |
gwascentral | rs2171492 |
openSNP | rs2171492 |
23andMe | rs2171492 |
SNPshot | rs2171492 |
SNPdbe | rs2171492 |
MSV3d | rs2171492 |
GWAS Ctlg | rs2171492 |
GMAF | 0.3292 |
Max Magnitude | 2 |
? | (G;G) (G;T) (T;T) | 28 |
---|---|---|
|
[PMID 19245716] (rs2171492, Cys303Gly) in CPA4 was associated with an increased risk of aggressive prostate cancer among younger ...
[PMID 19245716] Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer.
[PMID 22144497] Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection
[PMID 20205905] Association of repeatedly measured intermediate risk factors for complex diseases with high dimensional SNP data.
[PMID 20403199] High-throughput analysis of candidate imprinted genes and allele-specific gene expression in the human term placenta.
Categories:
- Is a snp
- In dbSNP
- SNPs on chromosome 7
- Has genotype
- Has population
- On chip 23andMe v1
- On chip 23andMe v2
- On chip 23andMe v3
- On chip 23andMe v4
- On chip Affy GenomeWide 6
- On chip Ancestry v2
- On chip FTDNA2
- On chip FTDNA
- On chip HumanOmni1Quad
- On chip Illumina Human 1M
- On chip 23andMe v5
- On chip Ancestry v2c
- On chip Ancestry v2d